NCT05066711View on ClinicalTrials.gov

NuVasive® ACP System Study

Enrolling by invitationOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

May 22, 2022

Primary Completion Date

January 30, 2025

Study Completion Date

January 30, 2026

Conditions
Cervical SpondylosisCervical RadiculopathyCervical MyelopathyCervical Disc DiseaseCervical StenosisCervical Disc HerniationCervical Spine Disease
Trial Locations (3)

28401

Atlantic Brain and Spine, Wilmington

60540

Duly Health and Care, Naperville

65201

Columbia Orthopedic Group Research, Columbia

Sponsors

Lead Sponsor

NuVasive
All Listed Sponsors
lead

NuVasive

INDUSTRY

NCT05066711 - NuVasive® ACP System Study | Biotech Hunter | Biotech Hunter